Description: A 30mg Retatrutide pen, as referenced in some research contexts, contains 300 units of 100mcg doses, designed for subcutaneous injection (arm, thigh, or stomach). It is typically cold-shipped, stable for up to a year when refrigerated (2–8°C), and not intended for human consumption.
Mechanism: Retatrutide targets three hunger-regulating hormones, suppressing appetite, slowing digestion, increasing fat metabolism, and improving insulin sensitivity. Clinical trials show up to 24–25% body weight loss in 48 weeks, outperforming drugs like Ozempic
Dosage: No standardized dosing exists yet. Research trials test varying doses (e.g., 1mg starting dose, titrated up to 5–15mg weekly). A 30mg pen would require careful reconstitution and dosing calculations, typically handled by researchers, not individuals.
